MEN1 and multiple endocrine neoplasia type 1: The identification of specific c-miRNA signatures associated with MEN1 syndrome and/or with different clinical phenotypes could help the diagnostic management of MEN1 syndrome and MEN1 tumors, in combination with MEN1 genetic testing and with the currently used clinical, biochemical, and radiological approaches.